Hepcidin mediates the disorder of iron homeostasis and mitochondrial function in mice under hypobaric hypoxia exposure

被引:0
作者
Liu, Jiayao [1 ]
Zhao, Jialin [1 ]
He, Jintao [1 ]
Li, Yuhui [1 ]
Xu, Jie [1 ]
Xiao, Chenxi [1 ]
Zhang, Yuyu [1 ]
Chen, Honghong [1 ]
Hu, Yajie [1 ]
Fan, Chunxiang [1 ]
Liu, Xinhua [1 ]
机构
[1] Fudan Univ, Shanghai Pudong Hosp, Human Phenome Inst, Dept Tradit Chinese Med, 825,Zhangheng Rd, Shanghai 201203, Peoples R China
基金
国家重点研发计划;
关键词
High-altitude; Iron metabolism; Hepcidin; Mitochondrial; Porphyrin metabolism; PEPTIDE HEPCIDIN; METABOLISM; ANEMIA; GENE; ADAPTATION; EXPRESSION;
D O I
10.1007/s10495-025-02079-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human body to prolonged high-altitude environments exposure can cause the decreased hepcidin and the disorder of iron homeostasis. Few animal studies have examined the molecular basis of iron metabolism disorder and the impact of hepcidin on the complex phenotype of high-altitude environments. In this study, we display reduced hepcidin level and impaired iron homeostasis upon hypobaric hypoxia, accompanied by mitochondrial dysfunction, abnormal blood cells and metabolic disorder. Importantly, mice overexpressing hepcidin show resistance to hypoxia-induced mitochondrial injury in liver and improve the body homeostasis. The comprehensive characterization of the metabolic pathways analysis demonstrates the porphyrin metabolism modulated by hepcidin may play a significant role in improving blood cell abnormalities upon high altitude hypoxia. In addition, hepcidin transcription is inhibited by histone modification and interruption of SMAD signaling pathway in hepatocytes in response to hypoxic stress to decrease hepcidin level. Our data highlight the key role of hepcidin in regulating the complex phenotype of high-altitude environments by altered metabolic and mitochondrial function. These results provide a theoretical reference to understanding the role of hepcidin in maintaining physiological function in high altitude, thus assisting in the development of strategies to better prevent and alleviate imbalance of energy homeostasis and adverse effects.
引用
收藏
页码:1076 / 1091
页数:16
相关论文
共 53 条
  • [11] Smith T.G., Talbot N.P., Privat C., Et al., Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials, JAMA, 302, pp. 1444-1450, (2009)
  • [12] Piperno A., Galimberti S., Mariani R., Et al., Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project, Blood, 117, pp. 2953-2959, (2011)
  • [13] Wang C.Y., Babitt J.L., Liver iron sensing and body iron homeostasis, Blood, 133, pp. 18-29, (2019)
  • [14] Galy B., Conrad M., Muckenthaler M., Mechanisms controlling cellular and systemic iron homeostasis, Nat Rev Mol Cell Biol, 25, pp. 133-155, (2024)
  • [15] Ganz T., Anemia of inflammation, N Engl J Med, 381, pp. 1148-1157, (2019)
  • [16] Muckenthaler M.U., Rivella S., Hentze M.W., Galy B., A Red Carpet for Iron Metabolism, Cell, 168, pp. 344-361, (2017)
  • [17] Brissot P., Loreal O., Iron metabolism and related genetic diseases: a cleared land, keeping mysteries, J Hepatol, 64, pp. 505-515, (2016)
  • [18] Meynard D., Babitt J.L., Lin H.Y., The liver: conductor of systemic iron balance, Blood, 123, pp. 168-176, (2014)
  • [19] Drakesmith H., Nemeth E., Ganz T., Ironing out Ferroportin, Cell Metab, 22, pp. 777-787, (2015)
  • [20] Park C.H., Valore E.V., Waring A.J., Ganz T., Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J Biol Chem, 276, pp. 7806-7810, (2001)